Reaction

Vulvovaginal Discomfort reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,348 reports · 32 co-occurring drugs

As of the last recalculation, Vulvovaginal Discomfort appears in 4,348 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is MICONAZOLE NITRATE (PRR 282.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Miconazole Nitrate460282.0297.8
Etonogestrel And Ethinyl Estradiol26761.362.1
Estradiol74549.650.0
Conjugated Estrogens28825.325.4
Estrogens, Conjugated28924.925.0
Estradiol Gel 0.1%16418.018.1
Estradiol Transdermal16418.018.1
Copper14516.616.7
Progesterone428.98.9
Drs. Clotrimazole197.97.9
Family Wellness Clotrimazole197.97.9
Clotrimazole Topical197.97.9
Clotrimazole197.47.4
Levonorgestrel2766.96.9
Tranexamic Acid105.45.4
Empagliflozin584.24.2
Biotin274.24.2
Lubiprostone84.14.1
Nitrofurantoin133.83.8
Nitrofurantoin (Monohydrate/Macrocrystals)133.73.7
Clobetasol Propionate Ointment Usp, 0.05%83.73.7
Anastrozole283.73.7
Anastrozole Tablets153.43.4
Canagliflozin203.23.2
Gefitinib63.23.2
Oxybutynin183.03.0
Dapagliflozin182.72.7
Ribociclib172.62.6
Multivitamin262.52.5
Conjugated Estrogens And Medroxyprogesterone Acetate112.22.2
Etonogestrel181.81.8
Drospirenone And Ethinyl Estradiol131.41.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.